Tell a friend
(Mandatory)
(Mandatory)
(Mandatory)
(Mandatory)

EPF Acknowledgement of financial support 2016

Industry related income
Name of company/ funder Amount of income % of overall organisation’s income
ALMIRALL € 5.000,00 0,26%
AbbVie € 25.000,00 1,32%
GILEAD € 20.000,00 1,05%
GSK € 60.000,00 3,16%
MSD € 58.891,61 3,10%
PFIZER € 67.700,00 3,55%
NOVARTIS € 60.000,00 3,16%
SANOFI PASTEUR MSD € 10.000,00 0,53%
Alexion € 10.000,00 0,53%
AIFP € 20.000,00 1,05%
Baxter World Trade € 10.000,00 0,53%
Celgene € 15.000,00 0,79%
Janssen € 30.000,00 1,58%
Eli Lilly € 15.000,00 0,79%
Hoffmann-La Roche € 40.000,00 2,110%
Vertex € 15.000,00 0,79%
Bosch Foundation € 20.000,00 1,05%
CSL Behring  € 10.000,00 0,53%
Grünenthal € 10.000,00 0,53%
Mylan € 10.000,00 0,53%
Sanofi-Aventis € 40.000,00 2,11%
Laboratoires Servier € 10.000,00 0,53%
Shire  € 10.000,00  0,53%
TEVA  € 20.000,00  1,05%
J&J   € 10.000,00  0,53%
Pharma industry EUPATI consortium cash pot (UCB, Amgen, Genzyme, VFA, AZ, Novonordisk, Bayer, Merck, Janssen, GSK, Chiesi, Hoffmann, Lilly, Novartis, Esteve)  € 62.709,74  3,30%
 Subtotal:  € 664.301,35  34.97%
   
Non-industry related income  
Source of funding Amount of income % of overall organisation’s income
European Commission € 731.835,98 38,52%
SmartCare € 4.600,59 0,24%
Eupati € 309.753,53 16,30%
Adapt Smart € 24.886,69 1,31%
Joint Action PASQ € 2.598,32 0,14%
Joint Action CHRODIS € 22.059,72 1,16%
Prefer € 1.594,45 0,08%
PISCE Self Care Tender € 4.421,70 0,23%
ProStep € 89.345,89 4,70%
Membership and subscriptions and other income € 44.360,23 2,34%
Subtotal: € 1.235.457,10 65,02%
 
TOTAL: € 1.899.758,45 100,00%